Search your symptoms with MEDgle. You can check your symptoms. It is a medical symptom search allowing you find out what options make sense for you.
CLOSE
PATIENT GPS
patients
healthcare providers
how it works
about
login
edit search
new search
symptoms
diagnoses
physicians
drugs
procedures
close
symptoms
diagnoses
drugs
procedures
physicians
symptom duration
0-3 days
4-14 days
2 weeks-2 months
2-6 months
6 months +
add symptom to current symptom search
same as above
0-3 days
4-14 days
2 weeks-2 months
2-6 months
6 months +
add symptom to current symptom search
same as above
0-3 days
4-14 days
2 weeks-2 months
2-6 months
6 months +
add symptom to current symptom search
same as above
0-3 days
4-14 days
2 weeks-2 months
2-6 months
6 months +
gender
male
female
age
1-3
4-11
12-17
18-29
30-50
50+
age
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
calculate
visual
[hide visual search]
search visually
symptoms
|
diagnoses
|
drugs
|
procedures
|
physicians
search symptoms
•
Find causes for your symptoms
•
Discover relevant types of physicians
search diagnoses
•
Understand the details of a diagnosis
•
Learn about relevant tests and treatments
•
Find useful resources on the web
search drugs
•
Learn about different therapeutic drugs
•
Understand what they are used for
•
Know the potential options
search procedures
•
Learn about different diagnostic and therapeutic procedures
•
Understand what they are used for
•
Know the potential options
search physicians
•
Find physicians in your area
•
Understand what they do
•
Get the right help you need
111in-dtpa-octreotide scintigraphy
reduced results from
148 billion
412 million
3 million
17490
to ~96 options
options split into images, definition, symptoms, related diagnoses, diagnostic tests, therapies, and medications
what is '111in-dtpa-octreotide scintigraphy'?
Definition for 111In-DTPA-octreotide scintigraphy
DTPA-octreotide scan type of nuclear scan for neuroendocrine tumors
111In-DTPA-octreotide scintigraphy is also known as: Octreotide scan, Octreotide scintigraphy, Somatostatin receptor scintigraphy, Somatostatin receptor scintigraphy (SRS), Somatostatin receptor scintigrapy, octreotide scanning, scintigraphy octreotide
111In-DTPA-octreotide scintigraphy is a medical procedure used for such diagnoses as: Cushing's disease or syndrome, carcinoid syndrome and medullary carcinoma thyroid.
related diagnosis for '111in-dtpa-octreotide scintigraphy'
1 - 5 of
10
diagnosis
Cushing's disease or syndrome
increased production of cortisol
111In-DTPA-octreotide scintigraphy and Cushing's disease or syndrome
carcinoid syndrome
symptoms caused by carcinoid tumorsl
111In-DTPA-octreotide scintigraphy and carcinoid syndrome
medullary carcinoma thyroid
cancer thyroid
111In-DTPA-octreotide scintigraphy and medullary carcinoma thyroid
multiple endocrine neoplasia type 1
disease affecting multiple endocrine glands
111In-DTPA-octreotide scintigraphy and multiple endocrine neoplasia type 1
pituitary adenoma
type of brain tumor
111In-DTPA-octreotide scintigraphy and pituitary adenoma
PPoma
rare pancreatic tumor
111In-DTPA-octreotide scintigraphy and PPoma
VIPoma
rare pancreatic tumor
111In-DTPA-octreotide scintigraphy and VIPoma
pheochromocytoma
tumor of adrenal gland
111In-DTPA-octreotide scintigraphy and pheochromocytoma
somatostatinoma
tumor of pancreas
111In-DTPA-octreotide scintigraphy and somatostatinoma
insulinoma
insulin producing tumor in pancreas
111In-DTPA-octreotide scintigraphy and insulinoma
for more please login, login is free (click to login)
related procedure for '111in-dtpa-octreotide scintigraphy'/associated diagnoses
1 - 5 of
53
procedures
Tumor markers
111In-DTPA-octreotide scintigraphy and Tumor markers
Chromogranin A
111In-DTPA-octreotide scintigraphy and Chromogranin A
CT scan
111In-DTPA-octreotide scintigraphy and CT scan
Abdominal CAT Scan
111In-DTPA-octreotide scintigraphy and Abdominal CAT Scan
Biopsy
111In-DTPA-octreotide scintigraphy and Biopsy
Brain MRI
111In-DTPA-octreotide scintigraphy and Brain MRI
Chest X-ray
Radiological technique to image the chest
111In-DTPA-octreotide scintigraphy and Chest X-ray
Serum chromogranin A
111In-DTPA-octreotide scintigraphy and Serum chromogranin A
Abdominal MRI
MRI of abdominal contents
111In-DTPA-octreotide scintigraphy and Abdominal MRI
CT chest
111In-DTPA-octreotide scintigraphy and CT chest
Magnetic Resonance Imaging (MRI) Chest
111In-DTPA-octreotide scintigraphy and Magnetic Resonance Imaging (MRI) Chest
Positron emission tomography (PET)
111In-DTPA-octreotide scintigraphy and Positron emission tomography (PET)
24 hour urinary catecholamine metabolites (metanephrines and normetanephrines)
24 hour urinary excretion of catecholamines metabolites
111In-DTPA-octreotide scintigraphy and 24 hour urinary catecholamine metabolites (metanephrines and normetanephrines)
Embolization
111In-DTPA-octreotide scintigraphy and Embolization
Molecular Genetic Studies
111In-DTPA-octreotide scintigraphy and Molecular Genetic Studies
Serum Catecholamines
111In-DTPA-octreotide scintigraphy and Serum Catecholamines
Serum Prolactin
111In-DTPA-octreotide scintigraphy and Serum Prolactin
serum gastrin
111In-DTPA-octreotide scintigraphy and serum gastrin
serum glucose
111In-DTPA-octreotide scintigraphy and serum glucose
24 hour Urinary 5-HIAA
111In-DTPA-octreotide scintigraphy and 24 hour Urinary 5-HIAA
for more please login, login is free (click to login)
related medication for '111in-dtpa-octreotide scintigraphy'/associated diagnoses
1 - 5 of
53
drugs
doxorubicin
111In-DTPA-octreotide scintigraphy and doxorubicin
octreotide
111In-DTPA-octreotide scintigraphy and octreotide
bromocriptine
111In-DTPA-octreotide scintigraphy and bromocriptine
cabergoline
111In-DTPA-octreotide scintigraphy and cabergoline
streptozotocin
111In-DTPA-octreotide scintigraphy and streptozotocin
diazoxide
111In-DTPA-octreotide scintigraphy and diazoxide
5-fluorouracil
111In-DTPA-octreotide scintigraphy and 5-fluorouracil
actinomycin d
111In-DTPA-octreotide scintigraphy and actinomycin d
alendronate
111In-DTPA-octreotide scintigraphy and alendronate
aminoglutethimide(cytadren )
111In-DTPA-octreotide scintigraphy and aminoglutethimide(cytadren )
bromocriptine(parlodel , bromocriptine mesylate)
111In-DTPA-octreotide scintigraphy and bromocriptine(parlodel , bromocriptine mesylate)
cisplatin
111In-DTPA-octreotide scintigraphy and cisplatin
cisplatin(platinol)
111In-DTPA-octreotide scintigraphy and cisplatin(platinol)
clonidine
111In-DTPA-octreotide scintigraphy and clonidine
corticorelin(acthrel )
111In-DTPA-octreotide scintigraphy and corticorelin(acthrel )
cyproheptadine
111In-DTPA-octreotide scintigraphy and cyproheptadine
dacarbazine
111In-DTPA-octreotide scintigraphy and dacarbazine
doxorubicin(adriamycin)
111In-DTPA-octreotide scintigraphy and doxorubicin(adriamycin)
esomeprazole
111In-DTPA-octreotide scintigraphy and esomeprazole
etoposide
111In-DTPA-octreotide scintigraphy and etoposide
for more please login, login is free (click to login)
The following are types of physicians relevant for '111In-DTPA-octreotide scintigraphy'.
related types of physicians 'endocrinologist, family practitioner, internist'
show local physicians
postal code
Find Local
stars represent relevance to topic not rating
more
The results are computer generated suggestions to help you find a physician. MEDgle does not recommend any particular type of physician or claim to be complete or accurate in the providers and specialties suggested.
web search results for '111in-dtpa-octreotide scintigraphy'?
Results
1 - 50
- 111In-DTPA-octreotide scintigraphy
[111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for ...
[111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of ... scintigraphy, but this radiopharmaceutical has some major drawbacks, which can ...
http://www.ncbi.nlm.nih.gov/pubmed/1658515
www.ncbi.nlm.nih.gov
-
summary
NIH Research Festival 2000
Synthesis of DTPA Analogues Derived From Piperidine and Azepane. ... 111-In-DTPA-Octreotide Scintigraphy (SRS) Is A Sensitive Method For Disease ...
http://researchfestival.nih.gov/festival01/sessions/CategoryIMAG.html
researchfestival.nih.gov
-
summary
Interpretation of the post-surgical Somatostatin Receptor Scintigram of ...
... Somatostatin Receptors Scintigraphy (SRS) with 111In-DTPA-D-Phe 1-pentetreotide. ... masses by indium-111-DTPA-D-Phe1-octreotide scintigraphy. J Nucl Med. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1079925
www.pubmedcentral.nih.gov
-
summary
[ 99m Tc]Cyclo(L-homocysteinyl-N-methyl-L-phenylalanyl-L-tyrosyl ...
... receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: ... 99mTc-depreotide, 111In-DTPA-octreotide, and 177Lu-DOTA-Tyr3-octreotate in a ...
http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=micad.chapter.Depreotide99mTc
www.ncbi.nlm.nih.gov
-
summary
Clinical uses of gut peptides.
... Chiti A, Boffi R, Invernizzi G, Crippa F, Maffioli L. Indium-111-DTPA-octreotide scintigraphy modulation by treatment with unlabelled somatostatin analogue in ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1190643
www.pubmedcentral.nih.gov
-
summary
2001 NIH Research Festival
Synthesis of DTPA Analogues Derived From Piperidine and Azepane. ... 111-In-DTPA-Octreotide Scintigraphy (SRS) Is A Sensitive Method For Disease ...
http://researchfestival.nih.gov/festival01/sessions/session3.html
researchfestival.nih.gov
-
summary
12368379 2002 10 07 2002 10 30 2006 11 15 0161-5505 43 10 2002 Oct J ...
... the spatial resolution of planar scintigraphy and SPECT prohibits imaging of ... of tumor uptake than can be obtained with 111In-DTPA-D-Phe1-octreotide and SPECT. ...
http://www.ncbi.nlm.nih.gov/pubmed/12368379
www.ncbi.nlm.nih.gov
-
summary
Carcinoid Tumor of the Kidney: Case Report and Review of the Literature
SR scintigraphy is recognized as an integral diagnostic and staging tool in the ... tumours with [111In] DTPA-octreotide scintigraphy (Octreoscan): a comparative ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1477585
www.pubmedcentral.nih.gov
-
summary
Nuclear medicine in the detection, staging and treatment of ...
The scintigraphy gives a good staging of the disease and detection of ... ( 111)Indium-DTPA-octreotide has been used as the first tumour-targeted treatment, ...
http://www.ncbi.nlm.nih.gov/pubmed/15763700
www.ncbi.nlm.nih.gov
-
summary
A Transplantable Human Carcinoid as Model for Somatostatin Receptor ...
Octreotide scintigraphy (left) of a nude mouse with a carcinoid tumor located in ... and dosimetry after repeated injections of 111In-DTPA-D-Phe1-octreotide. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1850312
www.pubmedcentral.nih.gov
-
summary
Section on Reproductive Medicine
... [18F]-fluorodeoxyglucose (FDG) PET, or [111In-DTPA-D-Phe]-pentetreotide (OCT) ... Octreotide is a useful adjunctive modality, but FDG-PET does not provide ...
http://2004annualreport.nichd.nih.gov/preb/srm.htm
2004annualreport.nichd.nih.gov
-
summary
Guidelines for the management of gastroenteropancreatic neuroendocrine ...
... receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the ... Ferguson R, Laird J. The octreotide suppression test and [111In-DTPA ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1867801
www.pubmedcentral.nih.gov
-
summary
Somatostatin receptors on neuroendocrine tumors--a way to ...
... detection using 111In-DTPA-D-Phe1-octreotide was evaluated in ... receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2588915
www.pubmedcentral.nih.gov
-
summary
[ 111 In-Diethylenetriaminepentaacetic acid-Pro 1 ,Tyr 4 ]bombesin ...
[ 111 In-DTPA-Pro 1 ,Tyr 4 ]BN differs from native BN in that pGlu 1 is replaced ... bombesin analogues for receptor-targeted scintigraphy and radiotherapy. ...
http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=micad.chapter.BNDTPA111In
www.ncbi.nlm.nih.gov
-
summary
Somatostatin-Rezeptor-Szintigrafie ? Wikipedia
... receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the ... u. a.: Receptor Scintigraphy with 111In-Pentetreotide for Endocrine ...
http://de.wikipedia.org/wiki/Somatostatin-Rezeptor-Szintigrafie
de.wikipedia.org
-
summary
Localization of neuroendocrine tumours with [111In] DTPA-octreotide ...
... tumours with [111In] DTPA-octreotide scintigraphy (Octreoscan): a comparative ... [ 111In]-octreotide scintigraphy has a higher sensitivity for tumour detection, ...
http://www.be-md.ncbi.nlm.nih.gov/pubmed/9666953
www.be-md.ncbi.nlm.nih.gov
-
summary
Octreotide scintigraphy. A new method for diagnosing pancreatic tumors.
1996 August; 224(2): 117?118. Copyright notice. Octreotide scintigraphy. ... receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1235330
www.pubmedcentral.nih.gov
-
summary
The use of somatostatin receptor scintigraphy in the differential ...
... receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the ... J, Pralet D, Stolz B, Koper JW, et al. [111In-DTPA-D-Phe1]-octreotide, ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1235331
www.pubmedcentral.nih.gov
-
summary
Cancer Medicine
The editors have strived to make every chapter in this book present the ... JE Eriksson B [111In-DTPA-d-Phe1] octreotide scintigraphy in patients with ...
http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=cmed6.biblist.20803
www.ncbi.nlm.nih.gov
-
summary
Zollinger-Ellison-Syndrom ? Wikipedia
... Usefulness of somatostatin receptor scintigraphy in the management of patients ... tumours with [111In] DTPA-octreotide scintigraphy (Octreoscan): a comparative ...
http://de.wikipedia.org/wiki/Zollinger-Ellison-Syndrom
de.wikipedia.org
-
summary
MULTIDISCIPLINARY SYMPOSIUM?NEUROENDOCRINE TUMOURS
111In-DTPA,D-Phe1-octreotide scintigraphy or OctreoScan ®, with single photon ... 111In-DTPA-Octreotide, also known as 111In-Pentetreotide and commercially ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1458416
www.pubmedcentral.nih.gov
-
summary
[ 111 In-Diethylenetriamine pentaacetic acid-ACMpip 5 ,Tha 6 ,?Ala 11 ...
[ 111 In-DTPA-Pro 1 ,Tyr 4 ]BN differs from native BN in that pGlu 1 is replaced ... bombesin analogues for receptor-targeted scintigraphy and radiotherapy. ...
http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=micad.chapter.ACMpip111In
www.ncbi.nlm.nih.gov
-
summary
Permeability of porcine blood brain barrier to somatostatin analogues
... receptor scans of 111In-DTPA-D-Phe1-octreotide localization detected all tumours. ... J.C. Somatostatin receptor scintigraphy in central nervous system ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1573221
www.pubmedcentral.nih.gov
-
summary
Multiple Endocrine Neoplasia Type 1 -- GeneReviews -- NCBI Bookshelf
... pentaacetic acid-octreotide [111In-DPTA octreotide]) is a proven ... Yearly chest CT, somatostatin receptor scintigraphy (SRS) octreotide scan ...
http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=men1
www.ncbi.nlm.nih.gov
-
summary
Use of the somatostatin analogue octreotide to localise and manage ...
... Somatostatin receptor scintigraphy (SRS) and octreotide therapy have both ... P, Pless J, Pralet D, Stolz B, Koper JW, et al. [111In-DTPA-D-Phe1]-octreotide, ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1727128
www.pubmedcentral.nih.gov
-
summary
Multiple Endocrine Neoplasia Type 1
diethylenetriamine pentaacetic acid-octreotide [ 111. In-DPTA octreotide]) is a proven ... Yearly chest CT, somatostatin receptor scintigraphy (SRS) octreotide scan ...
http://www.ncbi.nlm.nih.gov/bookshelf/picrender.fcgi?book=ge...
www.ncbi.nlm.nih.gov
-
summary
Isolation, Characterization, and Biological Evaluation of Syn and Anti ...
The success of 111In DTPA-octreotide stimulated the search for receptor-specific ... Receptor Scintigraphy in Rats and Comparison with [111In-DTPA-d-Phe1]Octreotide. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2330168
www.pubmedcentral.nih.gov
-
summary
The relevance of somatostatin receptors in thyroid neoplasia.
111In-octreotide scintigraphy in patients with persistent medullary thyroid ... tissue samples after intravenous injection of indium-111-DTPA-D-Phe-1-octreotide. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2589271
www.pubmedcentral.nih.gov
-
summary
Experience with indium-111 and yttrium-90-labeled somatostatin analogs.
... potential indications for SSTR scintigraphy are based on an increased ... high-dose treatment with (111)In-DTPA-DPhe(1)-octreotide, based on the emission ...
http://www.ncbi.nlm.nih.gov/pubmed/12171531
www.ncbi.nlm.nih.gov
-
summary
NIH CC: reynolds
In-111 DTPA-octreotide scintigraphy for disease detection in metastatic thyroid ... positron emission tomography and bone scintigraphy in the evaluation of bone ...
http://www.cc.nih.gov/drd/staff/james_reynolds.html
www.cc.nih.gov
-
summary
Metals in Medicine: Ta r gets, Diagnostics, and The r apeutics
Indium-111-DTPA-octreotide and 90Y-DOTA-Tyr3-octreotide are currently in ... effectively as 111In-DTPA-octreotide (a FDA approved imaging agent) and ...
http://www.nigms.nih.gov/NR/rdonlyres/10B078EE-A7F6-4363-BEC...
www.nigms.nih.gov
-
summary
Possible Primary Lymph Node Gastrinoma: Occurrence, Natural History ...
... scintigraphy was performed since 1994 using [111In-DTPA-DPhe1]-octreotide (6 ... This tumor was not demonstrated by octreotide scan. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1514510
www.pubmedcentral.nih.gov
-
summary
Immunohistochemical Localization of Somatostatin Receptors sst2A in ...
12 The 111In-labeled DTPA-octreotide radioligand is therefore particularly ... B: Positive somatostatin receptor scintigraphy correlates with the presence of ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1852945
www.pubmedcentral.nih.gov
-
summary
99m Tc-ethylenediamine N,N' -diacetic acid/hydrazinonicotinamide-Tyr 3 ...
... positive tumors: preclinical evaluation and comparison with 111In-octreotide. ... mediated scintigraphy and localization using (99m)Tc-HYNIC-Tyr(3)-octreotide in ...
http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=micad.chapter.HYNICTOC99mTc
www.ncbi.nlm.nih.gov
-
summary
Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray"
... correlated with high uptake during [111In-DTPA0] octreotide scintigraphy. ... receptor positive tumours: comparison of 86Y-DOTATOC and 111In-DTPA-octreotide. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1914264
www.pubmedcentral.nih.gov
-
summary
In vivo and in vitro effects of octreotide, quinagolide and cabergoline ...
... and dopamine receptor scintigraphy and to the immunohistochemical ... AND PATIENTS: Scintigraphy using 111In-DTPA-D-Phe(1)-OCT (111In-OCT) and 123I ...
http://www.ncbi.nlm.nih.gov/pubmed/11318782
www.ncbi.nlm.nih.gov
-
summary
Somatostatin analogue treatment of neuroendocrine tumours.
Octreotide, but not bromocriptine, increases circulating insulin-like growth ... receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2398518
www.pubmedcentral.nih.gov
-
summary
Human somatostatin receptor mediated antiproliferative action evokes ...
... scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, ... and in rats of 161Tb-DTPA-octreotide, a somatostatin analogue with potential for ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2589268
www.pubmedcentral.nih.gov
-
summary
NIH Research Festival 2001
Synthesis of DTPA Analogues Derived From Piperidine and Azepane. ... 111-In-DTPA-Octreotide Scintigraphy (SRS) Is A Sensitive Method For Disease ...
http://researchfestival.nih.gov/festival01/sessions/printsession3.html
researchfestival.nih.gov
-
summary
Fortnightly review: The role of nuclear medicine in clinical investigation
111In-pentetreotide scintigraphy is most commonly used in the assessment of ... Positive uptake is regarded as a prelude to treatment with radiolabelled octreotide. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1112941
www.pubmedcentral.nih.gov
-
summary
Fates of endocytosed somatostatin sst2 receptors and associated agonists.
... receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the ... and somatostatin receptor scintigraphy for diagnosis and treatment ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1219870
www.pubmedcentral.nih.gov
-
summary
[ 111 In-1,4,7,10-Tetraazacyclododecane- N , N' , N'' , N ...
[ 111 In-DTPA-Pro 1 ,Tyr 4 ]BN differs from native BN in that pGlu 1 is replaced ... bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy. ...
http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=micad.chapter.BNDOTA111In
www.ncbi.nlm.nih.gov
-
summary
Identification of occult metastases of medullary thyroid carcinoma by ...
Baudin E. Comparison of octreotide scintigraphy and conventional imaging in ... receptor scintigraphy with [111In-DTPA-D-Phe1] and [123I-Tyr3]-octreotide: the ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1859979
www.pubmedcentral.nih.gov
-
summary
Selection of Radiolabeled Gastrin Analogs for Peptide Receptor?Targeted ...
... with medullary thyroid cancer imaged with 111In-DTPA d-Glu-minigastrin. ... A study comparing octreotide and minigastrin scintigraphy showed that in >20% of ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2246928
www.pubmedcentral.nih.gov
-
summary
Functional scintigraphy of the adrenal gland.
... of somatostatin receptors ((123)I-tyr-octreotide, (111)In-DTPA-octreotide, (111)In-DOTA-octreotide and many others); (d) although not specific for the ...
http://www.ncbi.nlm.nih.gov/pubmed/12088915
www.ncbi.nlm.nih.gov
-
summary
The biology and clinical relevance of somatostatin receptor ...
... receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the ... radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2589262
www.pubmedcentral.nih.gov
-
summary
Comparison of Surgical Results in Patients With Advanced and Limited ...
... Kwekkeboom DJ, Bakker WH, et al. Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pub...
www.pubmedcentral.nih.gov
-
summary
Resolved and Unresolved Controversies in the Surgical Management of ...
... Kwekkeboom DJ, Bakker WH, et al. Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pub...
www.pubmedcentral.nih.gov
-
summary
Preoperative localization of gastrointestinal endocrine tumors using ...
Scintigraphy, CT, and US showed comparable results in the detection of ... P, Pless J, Pralet D, Stolz B, Koper JW, et al. [111In-DTPA-D-Phe1]-octreotide, ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1243035
www.pubmedcentral.nih.gov
-
summary
Nuclear medicine imaging and therapy of neuroendocrine tumours
... receptor scintigraphy (SRS) with 111In-DTPA-octreotide mainly visualises ... 3-octreotide: First results in patients and comparison with 111In-DTPA-D-Phe 1 ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1805059
www.pubmedcentral.nih.gov
-
summary
show more
1
2
Chat with eNurse Kim about '111In-DTPA-octreotide scintigraphy' or something else!
quick facts
related diagnosis category
endocrine
faq/about
|
disclaimer
|
privacy policy
|
terms of service
|
browse
|
beta
|
contact
|
API - Catalyst
|
advertise
MEDgle does not provide medical advice, diagnosis or treatment. Copyright 2006-2011, MEDgle Inc. All Rights Reserved. MEDgle is NOT affiliated with Google. Last Updated: July 24, 2011
This site complies to the
HONcode standard for trustworthy health
information:
verify here
.
Invited Sponsor for Communications Conference
Finalist -- search & reference
MEDgle has been selected for the 2009 Best of Business Award in the Medical research